Cardiac Magnetic Resonance Utilities in the Evaluation of Ischemic Heart Disease (CARDIO-RM)

September 30, 2016 updated by: Ettore Sansavini Health Science Foundation

CARDIAC MAGNETIC RESONANCE UTILITIES IN THE EVALUATION OF ISCHEMIC HEART DISEASE: Topographical Correlation Between Ischemic Territory Injury and Coronary Angiography

The purpose of this study is to evaluate CARDIAC MAGNETIC RESONANCE UTILITIES IN THE ISCHEMIC HEART DISEASE as topographical correlation between ischemic territory injury and coronary angiography.

Study Overview

Status

Completed

Conditions

Detailed Description

Assessing the accuracy of Cardio-RM identifying ischemic territories and their correspondence to the presence of critical coronary lesions, comparing the presence, extent and regional inducible ischaemia in the Cardiac-MRI with the presence and characteristics of vascular lesions in coronary angiography.

In particular, the study aims to evaluate the correlation between topography and function of the ischemic area revealed by the resonance and coronary artery disease documented coronary angiography.

Study Type

Observational

Enrollment (Actual)

146

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • RA
      • Cotignola, RA, Italy, 48010
        • Maria Cecilia Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who refer to the clinic within 12 months, with diagnosis of suspected coronary artery disease (CAD) or recurrent ischemic symptoms assessed by under-effort angina symptoms and/or cardiac conventional stress test, and the presence of at least two risk factors.

Description

Inclusion Criteria:

  1. patients with suspected ischemic heart disease or recurrent Myocardial ischemic symptoms defined as:

    • presence of:

      • chest pain related to the effort lasting 5-20 minutes, and / or
      • positive stress test for inducible Myocardial ischemia
    • presence of at least one of the following risk factors: smoke family history of cardiovascular disease hypertension dyslipidemia diabetes mellitus NID / ID
  2. no contraindications to perform coronary angiography
  3. informed written consent to the processing of personal and sensible data, signed and dated by the patient.

Exclusion Criteria:

  • Unstable angina;
  • Severe aortic stenosis
  • Hypertrophic cardiomyopathy
  • Pacemaker and \ or defibrillator
  • Coronary stent implantation in 90 days before Cardiac MRI
  • Intracranial metal clips
  • Severe hypertension (systolic blood pressure> 240 mmHg, and diastolic blood pressure above 120 mmHg)
  • Ventricular thrombosis and \ or atrial
  • Aortic aneurysm and \ or aortic dissection
  • Myocarditis, endocarditis, pericarditis
  • Critical stenosis of the left notes
  • State of severe anxiety or claustrophobia
  • Contraindications to the use of atropine (BAV advanced glaucoma, pyloric stenosis, prostatic hypertrophy)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
suspected Myocardial Ischemia
Patient with diagnosis of suspected coronary artery disease (CAD) or recurrent ischemic symptoms assessed by under-effort angina symptoms and/or cardiac conventional stress test, and the presence of at least two risk factors.
Cardiac magnetic resonance - dipyridamole or dobutamine MRI stress test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of Cardio-RM identifying ischemic territories
Time Frame: 1 month
Assessing the accuracy of Cardio-RM identifying ischemic territories and their correspondence to the presence of critical coronary lesions, comparing the presence, extent and regional inducible ischaemia in the Cardiac-MRI with the presence and characteristics of vascular lesions in coronary angiography.
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
correlation between resonance and coronary artery disease documented coronary angiography.
Time Frame: 1 month
comparison of diagnostic positivity for inducible ischemia assessed by Cardiac-MRI and the presence of coronary lesions of various degrees evaluated by coronary angiography
1 month
topographic correlation between ischemic territory and coronary lesions
Time Frame: 1 month
topographic correlation between ischemic territory assessed by Cardiac-MRI and coronary lesions evaluated by coronary angiography, using the criteria defined in Sintax study and BARI study.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (ACTUAL)

December 1, 2014

Study Completion (ACTUAL)

March 1, 2015

Study Registration Dates

First Submitted

July 18, 2011

First Submitted That Met QC Criteria

July 18, 2011

First Posted (ESTIMATE)

July 19, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

October 3, 2016

Last Update Submitted That Met QC Criteria

September 30, 2016

Last Verified

May 1, 2015

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Ischemia

Clinical Trials on Cardiac magnetic resonance - CINE MRI stress test.

3
Subscribe